Policy
It is the policy of The University of
Minnesota Duluth, that all
scientists, researchers and principal investigators, who are planning
to undertake research projects involving the use of Hazardous
Biological Microorganisms, Biological Toxins and Artificial Gene
Transfer / Recombinant DNA, must submit Usage Forms and Written
Experimental Protocols, to the university Bio-Safety Officer (BSO) for
review and approval, prior to the start of any such experiments, as
required by the University of Minnesota Institutional Bio-Safety
Committee (IBC).
For experiments or work involving
the use of Human Blood, Blood Products and Components, Human Secretion,
Body Fluids, Human Tissues or Organs, compliance with the OSHA
Bloodborne Pathogens Standard (29CFR 1910.1030) is required. No
IBC approval is necessary. However, a submission of a Written
Experimental Protocol is desired.
Written Experimental Protocols must
at least,
- provide a brief description of
the pathogenicity and public health aspects of the agent used,
- describe the safe methods to be
used for handling, containing and storing the agent, including
Bio-Safety Levels (BSL: 2,3),
- describe the procedure to be
used for decontaminating, area, material and objects during normal
procedure and upon spill of the agent or material.
Also, to insure that safe and prudent
work practices are followed; researchers may commence such experiments
only if all personnel directly or indirectly involved in the handling,
manipulation, containment, decontamination and disposal of known and
potentially infectious bio-hazardous or pathogenic agents and
materials, have had necessary and appropriate training,
were made familiar with the requirements of this plan and will strictly
adhere to the guidelines described herein.
Biosafety Level 4 (BSL4) is not allowed at UMD.
|
